Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to ...

Mounjaro (tirzepatide) is a brand-name injection prescribed for type 2 diabetes in ... This list doesn’t include all possible mild side effects of the drug. For more information, you can refer ...

Sotagliflozin, a newly FDA-approved medication for treating type 2 diabetes and kidney disease with added cardiovascular risks, has been shown to greatly lower the risk of heart attacks and ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.